Save Article

Study Suggests Genentech Drug Curbs
Growth of Veins That Feed Tumors

By

David P. Hamilton Staff Reporter of The Wall Street Journal

Updated March 21, 2002 12:01 a.m. ET

Harvard University researchers found that a cancer treatment from Genentech Inc. can curb the growth of the blood vessels that feed tumors, evidence that some new targeted cancer treatments may attack tumors on several fronts at once.

The results -- from research on mice -- don't have immediate significance for the treatment of human cancer. But the unexpected finding suggests that newer cancer drugs designed to gum up the molecular workings of cancer cells may broadly inhibit tumor blood-vessel growth as well, a process known...